SENSEX NIFTY

Glaxo

Sep 03, 2014 at 11:43 | Source: Moneycontrol.com
On Monday, Mumbai-based generic drugmaker Cipla launched the aerosol copy of GlaxoSmithKlines anti-asthma inhaler Adviar in two small European markets Germany and Sweden but the move could potentially serve as a precursor to a crack at more lucrative markets such as the US and the UK.
Sep 02, 2014 at 10:22 | Source: Moneycontrol.com
Though analysts are impressed by its earlier- than-expected launch, most of them have not yet upgraded Cipla yet. Credit Suisse maintains a neutral rating on it stating base case is already priced in. According to the brokerage, Germany and Sweden are small markets but the launch signifies approval in the UK could be expected by FY15-end.
Aug 30, 2014 at 14:32 | Source: CNBC-TV18
Last week, GSK consumer healthcare re-launched it's flagship health drink Horlicks with a new logo, packaging and commercial. Pavni Mittal of Storyboard caught up with Jayant Singh to understand the changes made to the brand and how it would be marketed.
Aug 28, 2014 at 10:04 | Source: Reuters
In addition, a steering committee made up of senior officials from NIH and the Department of Defense last week approved the first step toward using three advanced laboratories to manufacture Ebola vaccines and treatments, a person familiar with the planning said.
Aug 25, 2014 at 08:30 | Source: IBNLive.com
In the latest list for the year 2014, ITC is followed by engineering and infrastructure major Larsen and Toubro (L&T), another FMCG giant Hindustan Unilever, carmaker Maruti Suzuki and public sector bank SBI among the top five most admired companies in India.
Aug 12, 2014 at 14:44 | Source: PTI
The company follows January-December financial year. "The quarter continued to see the impact of the base effect of differential pricing cuts due to price control order, extending coverage to the National List of Essential Medicines (NLEM)," the company said.
Aug 11, 2014 at 16:32 | Source: Moneycontrol.com
Sharekhan has recommended hold rating on GlaxoSmithKline Consumer Healthcare with a target price of Rs 4990, in its research report dated August 07, 2014.
Aug 09, 2014 at 13:48 | Source: Moneycontrol.com
Brokerage house Emkay Global Financial Services is bullish on GlaxoSmithKline Consumer Healthcare and has recommended buy rating on the stock with a target price of Rs 5112 in its August 07, 2014 research report.
Aug 09, 2014 at 13:40 | Source: Moneycontrol.com
Motilal Oswal has maintained a 'Neutral' rating on GlaxoSmithKline Consumer Healthcare with a target price of Rs 4400, in its August 06, 2014 research report.
Aug 08, 2014 at 14:45 | Source: CNBC-TV18
According to Varun Lohchab, Regional Head of Consumer at CIMB Equities, ITC and Marico are the top picks in consumer staples.
Messages on Glaxo »

amit kumar

Silver Member

12 Followers

Global Offshore  

I told already that news by media that India Star Fund will sell to a MNC & this Company will become MNC. ... Now pay the share price of MNC ( like NOVARTIS, SEIMENS, GLAXO, PFIZER etc)

3.36 PM Jul 7th

arinshare

Gold Member

6 Followers

MF Investment Help  

Dear Soporofic, I take fancy of two stocks - GlaxoSmithKline Pharmaceuticals and GlaxoSmithKline Consumer Healthcare. Please share your stand on its future prospects. Another point I like to know how do you buy or pick stock right now at this life time high market? What is your conviction

4.08 PM Jul 6th

Web Messenger

Platinum Member

236173 Followers

GlaxoSmithKline  

Source:BBC - Allegations that pharmaceutical giant GlaxoSmithKline (GSK) systematically bribed doctors in China are credible, says an investigator hired by the firm. Peter Humphrey was hired only to investigate who was behind a suspected smear campaign against GSK. But after he finished his report

3.50 PM Jul 4th

Web Messenger

Platinum Member

236173 Followers

GlaxoSmithKline  

Source:BBC - To observers of China`s contemporary business culture it will come as no great surprise that the latest twist in GlaxoSmithKline`s China crisis is a sex tape. The secret filming of business, political and love rivals in intimate situations is now commonplace in China and motivations

3.50 PM Jul 4th

Expert Chartist

Platinum Member

9779 Followers

GlaxoSmithKline  

At 12:00 hrs GlaxoSmithKline has formed a bearish bar reversal chart pattern today. A Bearish Bar Reversal occurs when today\'s high is higher than its previous day high and the current price / today\'s close is lower than its previous day close.

12.00 PM Jul 4th

Omar_An

Silver Member

0 Follower

GlaxoSmithKline  

USA-based Isis Pharmaceuticals has earned yet another $1 million payment from UK pharma giant GlaxoSmithKline.

11.09 AM Jul 4th

PipaDove

New Member

0 Follower

GlaxoSmithKline  

3000 just round the corner. Buy and wait! - My target for GlaxoSmithKline is Rs 3000 for the short term with a stoploss of Rs 2545

10.42 AM Jul 4th

BSE/NSE Announcer

Platinum Member

4047 Followers

GlaxoSmith Con  

GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that in accordance with the Companys Policy on Insider Trading, the date of commencement of closing of "Trading Window" shall be from July 03, 2014 and shall end 24 hours after public announcement of the Quarterly Financial Result

5.40 PM Jul 2nd

Expert Chartist

Platinum Member

9779 Followers

GlaxoSmith Con  

At 11:56 hrs GlaxoSmith Con has formed a bearish bar reversal chart pattern today. A Bearish Bar Reversal occurs when today\'s high is higher than its previous day high and the current price / today\'s close is lower than its previous day close.

12.00 PM Jul 1st

MMB Messenger

Platinum Member

241328 Followers

Aurobindo Pharm  

Chat Transcript from Ajay Jain. Question sammin22: Sir..view on Aurobindo for July series Answer: It is better to go for investment in front line Pharma stocks like Ranbaxy, Dr Reddy , Glaxo etc.

5.36 PM Jun 30th

News across the web »
Sep 02, 2014 at 12:00 | Source: NDTV Profit
Aug 29, 2014 at 02:15 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.